Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Solmi

Showing results (561-570 of 583) with videos related to

Pageof 59
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderatorsMarco Solmi, Giovanni Croatto, Arnav Gupta, et al.
Clinical and Translational Science|October 31, 2021
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance databaseSe Yong Jung, Min Seo Kim, Han Li, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
Advances in Nutrition (Bethesda, Md.)|June 4, 2020
Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational StudiesKeum Hwa Lee, Hyo Jin Seong, Gaeun Kim, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stagesPaolo Fusar-Poli, Toby Pillinger, Robert A McCutcheon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 8, 2025
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysisMikkel Højlund, Helin Y Kafali, Begüm Kırmızı, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2024
Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophreniaMarco Solmi, Giovanni Croatto, Nicholas Fabiano, et al.
The Lancet. Psychiatry|January 8, 2026
Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysisElias Wagner, Mikkel Højlund, Jess G Fiedorowicz, et al.
BMJ (Clinical Research Ed.)|November 26, 2025
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision makingCorentin J Gosling, Miguel Garcia-Argibay, Michele De Prisco, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 16, 2024
Health trends in Canada 1990-2019: An analysis for the Global Burden of Disease StudyJacek A Kopec, Farshad Pourmalek, Daniel A Adeyinka, et al.
Pageof 59

Showing results (561-570 of 583) with videos related to

Sort By:
Pageof 59
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 9, 2024
Effects of antipsychotic treatment on cardio-cerebrovascular related mortality in schizophrenia: A subanalysis of a systematic review and meta-analysis with meta-regression of moderatorsMarco Solmi, Giovanni Croatto, Arnav Gupta, et al.
Clinical and Translational Science|October 31, 2021
Cardiovascular events and safety outcomes associated with remdesivir using a World Health Organization international pharmacovigilance databaseSe Yong Jung, Min Seo Kim, Han Li, et al.
The Lancet. Psychiatry|August 14, 2025
Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the Lancet Psychiatry Physical Health CommissionSean Halstead, Chloe X Yap, Nicola Warren, et al.
Advances in Nutrition (Bethesda, Md.)|June 4, 2020
Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational StudiesKeum Hwa Lee, Hyo Jin Seong, Gaeun Kim, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2026
Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stagesPaolo Fusar-Poli, Toby Pillinger, Robert A McCutcheon, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 8, 2025
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysisMikkel Højlund, Helin Y Kafali, Begüm Kırmızı, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 3, 2024
Sex-stratified mortality estimates in people with schizophrenia: A systematic review and meta-analysis of cohort studies of 2,700,825 people with schizophreniaMarco Solmi, Giovanni Croatto, Nicholas Fabiano, et al.
The Lancet. Psychiatry|January 8, 2026
Disparities in diabetes treatment and monitoring for people with and without mental disorders: a systematic review and meta-analysisElias Wagner, Mikkel Højlund, Jess G Fiedorowicz, et al.
BMJ (Clinical Research Ed.)|November 26, 2025
Benefits and harms of ADHD interventions: umbrella review and platform for shared decision makingCorentin J Gosling, Miguel Garcia-Argibay, Michele De Prisco, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|February 16, 2024
Health trends in Canada 1990-2019: An analysis for the Global Burden of Disease StudyJacek A Kopec, Farshad Pourmalek, Daniel A Adeyinka, et al.
Pageof 59